Prevention of autoimmune rheumatic disease: state of the art and future perspectives

被引:70
作者
Klareskog, Lars [1 ,2 ]
Gregersen, Peter K. [3 ]
Huizinga, Tom W. J. [4 ]
机构
[1] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm 17176, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA
[4] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONGENITAL HEART-BLOCK; CITRULLINATED PROTEIN ANTIBODY; PLACEBO-CONTROLLED TRIAL; MONOCLONAL AUTOANTIBODIES; ALCOHOL-CONSUMPTION; DOUBLE-BLIND; ARTHRITIS; RISK; SMOKING;
D O I
10.1136/ard.2010.142109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention of disease can in principle be accomplished by identification of environmental and/or lifestyle risk and protective factors followed by public health measures (such as for smoking and lung cancer), or by modification of the individual's reactions to disease-inducing factors (such as in vaccinations against microbes). This review discusses both options based on emerging understanding of aetiologies in inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The major current opportunity for public health-based prevention lies in avoiding smoking. In RA, recent studies have calculated that, in Sweden (a country characterised by a low frequency of smoking), 20% of all RA cases and 33% of all cases of ACPA-positive RA would not have occurred in a smoke-free society. Smoking is also a major risk factor for SLE but no population attribution is yet available. New avenues for individualised and biology-based prevention are provided by the demonstration that several autoimmune rheumatic diseases are preceded by emergence of subclinical autoimmunity followed by laboratory-based signs of inflammation and finally overt disease. Examples of this process are provided from studies of autoimmunity to citrullinated proteins (in RA), to dsDNA (in SLE in general) and to Ro52 epitopes (in the case of neonatal heart block). The recognition of this sequence of events provides opportunities to intervene specifically and potentially curatively before onset of full-blown disease. Such prevention can be accomplished by modification of inciting antigens (environment), by modification of immunity (more or less specific immunomodulation) or by modification of specific gene functions. In all cases, prevention will be different in different subsets of disease and differ at different time points of disease development. Thus, the road map towards prevention of autoimmune rheumatic diseases includes increased understanding of how genes, environment and immunity interact.
引用
收藏
页码:2062 / 2066
页数:5
相关论文
共 57 条
  • [1] Development of autoantibodies before the clinical onset of systemic lupus erythematosus
    Arbuckle, MR
    McClain, MT
    Rubertone, MV
    Scofield, RH
    Dennis, GJ
    James, JA
    Harley, JB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) : 1526 - 1533
  • [2] Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
    Baechler, EC
    Batliwalla, FM
    Karypis, G
    Gaffney, PM
    Ortmann, WA
    Espe, KJ
    Shark, KB
    Grande, WJ
    Hughes, KM
    Kapur, V
    Gregersen, PK
    Behrens, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) : 2610 - 2615
  • [3] Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies
    Baudino, Lucie
    da Silveira, Samareh Azeredo
    Nakata, Munehiro
    Izui, Shozo
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 28 (02): : 175 - 184
  • [4] Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study
    Bengtsson, Camilla
    Kapetanovic, Meliha C.
    Kallberg, Henrik
    Sverdrup, Berit
    Nordmark, Birgitta
    Klareskog, Lars
    Alfredsson, Lars
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) : 1831 - 1833
  • [5] Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial
    Bos, W. H.
    Dijkmans, B. A. C.
    Boers, M.
    van de Stadt, R. J.
    van Schaardenburg, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 571 - 574
  • [6] Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis
    Choi, Je-Min
    Kim, Seung-Hyung
    Shin, Jae-Hoon
    Gibson, Thomas
    Yoon, Byoung-Seok
    Lee, Dong-Ho
    Lee, Seung-Kyou
    Bothwell, Alfred L. M.
    Lim, Jong-Soon
    Lee, Sang-Kyou
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (50) : 19875 - 19880
  • [7] Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents
    Cooper, Glinda S.
    Wither, Joan
    Bernatsky, Sasha
    Claudio, Jaime O.
    Clarke, Ann
    Rioux, John D.
    Fortin, Paul R.
    [J]. RHEUMATOLOGY, 2010, 49 (11) : 2172 - 2180
  • [8] Cigarette smoking and the risk of systemic lupus erythematosus - A meta-analysis
    Costenbader, KH
    Kim, DJ
    Peerzada, J
    Lockman, S
    Nobles-Knight, D
    Petri, M
    Karlson, EW
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (03): : 849 - 857
  • [9] Preclinical Rheumatoid Arthritis: Identification, Evaluation, and Future Directions for Investigation
    Deane, Kevin D.
    Norris, Jill M.
    Holers, V. Michael
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (02) : 213 - +
  • [10] Different Patterns of Associations With Anti-Citrullinated Protein Antibody-Positive and Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis in the Extended Major Histocompatibility Complex Region
    Ding, Bo
    Padyukov, Leonid
    Lundstrom, Emeli
    Seielstad, Mark
    Plenge, Robert M.
    Oksenberg, Jorge R.
    Gregersen, Peter K.
    Alfredsson, Lars
    Klareskog, Lars
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (01): : 30 - 38